I'd like to answer them all, but I will start by saying that I don't believe, with all due respect, that voluntary donations are an answer. Mr. Williams has quoted that something like $235 million worth of product has been donated by brand-name pharmaceuticals since 1990. When you divide that by the number of years and the number of companies, that's $265,000 a year. That does not substantially address any issue in the southern world.
Second, preferential pricing would still only bring prices down to one-quarter of the price in the developed world, whereas generic competition has dropped the prices 17 times over against brand-name prices. The generics have to be part of the picture. It's not an option. That's where the action is. That's what's saving lives right now.
Also I just have to take issue with some of the comments. I believe it was Mr. Williams who said that he regretted that time was being wasted on Bill C-393 when we could be spending our time more fruitfully coming up with answers to some of the other kinds of issues of infrastructure and sanitation and all those sorts of things. I believe the House of Commons is the body that decided Bill C-393 was deserving of the attention of this committee, and we are doing House of Commons business, the business of Canadians, and it's right that we do it well.